+
Site Tour
Welcome

CONNEXT by Advanced Heart Therapies from Abbott offers personalized educational content, case clubs, expert opinions, and opportunities for networking with peers to raise your learning experience in cardiovascular and stroke prevention therapies.

Please register or login to experience content that is tailored to your needs.
 

Sign in   Register

THE MOST DURABLE DATA.1

Anything less is just marketing.

 

Explore now

2-Year OUTCOMES from
the triluminate pivotal trial

New TriClip™ Transcatheter Edge-to-Edge Repair clinical data released
 

EXPLORE NOW

TREATING LARGE ANNULI WITH 35MM NAVITOR VISION

Achieving optimal outcomes for treatment of large annuli with 35 mm Navitor Vision Valve
 

WATCH LIVE CASE

PFO CLOSURE WEBINAR IN PATIENTS>60

Latest clinical results in patients >60 years and impact in clinical practice.
 

WATCH NOW

TAVI IN A SMALL AORTIC ANNULUS

Now you’ve got Navitor in Small Aortic Annuli: Single-Digit Mean Gradients
 

Explore Now

AMPLATZER™ AMULET LAA™ OCCLUDER

Five-Year Results from Amulet™ LAAO Randomized Controlled Trial.
 

EXPLORE NOW

join the community   •   REGISTER TO RECEIVE THE LATEST UPDATES

Trending Now

Treating Large annuli with 35mm Navitor Vision

Achieving optimal outcomes for treatment of large annuli with 35 mm Navitor Vision Valve

PCR Webinar on secondary mitral regurgitation

New evidence reshaping the management of secondary mitral regurgitation

Navitor Valve in small aortic annuli

Now you’ve got Navitor for TAVI in small aortic annuli (SAA)

2-year outcomes from the TRILUMINATE Pivotal trial

2-year outcomes from the TRILUMINATE Pivotal trial

Safety with TriClip TEER

When it comes to safety, TriClip TEER is proven
F. Sarnago, P. Lurz, A. Asgar

The Amulet IDE Trial

Five Year Results fom Amulet™ LAA Randomized Controlled Trial

Amplatzer™ Amulet™ LAA Occluder

Concomitant Catheter Ablation and LAA Occlusion with the Amplatzer™ Amulet™

Abbott TMTI at PCRLV - recorded cases and more

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation | PCR LV '24

Abbott TMTI sponsored symposium at PCRLV 2024

Unlocking the potential of mitral and tricuspid valves clipping | PCR London Valves 2024

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

Transfemoral TAVI

Navitor Vision 35 implantation

Epic Mitral – 10-Year Clinical Outcomes

Ten-Year Follow-Up of Mitral Valve Replacement With the Epic Porcine Valve

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Webinar PFO closure in patients >60 Years

Webinar PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

Connext
TV

Visit our dedicated channel 
for the latest videos, animations 
and interviews.
 

Find out more

Connext
Hub

Learn emerging and established information on cardiovascular conditions and stroke prevention technologies.

Find out more

Therapies

Valvular Diseases

Mitral Valve DiseaseAortic Valve DiseaseTricuspid Valvle DiseaseParavalvular Leak

Stroke

Stroke Associated with PFOStroke Associated with Atrial Fibrillation

Congenital Heart Diseases

Patent Ductus Arteriosus

Heart Failure

Heart Failure Disease

SOLUTIONS

AMPLATZER™ TALISMAN™ PFO

AMPLATZER™ DUCT™OCCLUDER

AMPLATZER™ PICCOLO OCCLUDER

CARDIOMEMS™ HF SYSTEM

Connext
Live

REGISTER FOR OUR
VIRTUAL VENUE

Hear expert opinions first hand and collaborate on best practices.

Find out more

References
  1. Stone et al., 2023 NEJM COAPT 5-Year Outcome. Feldman et al., 2015 JACC 5 Yr EVEREST II RCT. Nickenig et al., 2024 JACC 3-Year Outcomes from the TRILUMINATE Study.

© Abbott 2025. All rights reserved. 9-EH-5-14584-01 04-2025 REV I

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline